BenevolentAI uses cognitive computing, semantic search to speed development of in-licensed drugs December 6, 2016December 6, 2016 by timbatchelder, posted in Social Business A key ambition of BenevolentAI is to use artificial intelligence to revolutionize the drug development process. Now, with a licensing agreement with Janssen, it is one significant step closer to realizing that dream. Source: BenevolentAI looks to artificial intelligence for speedy development of in-licensed drugs | FierceBiotech Rate this:Share this:EmailTumblrFacebookRedditLinkedInPrintPocketPinterestTwitterWhatsApp Related